SBRT group n = 27 | 3DCRT group n = 28 | p-value | |||
---|---|---|---|---|---|
n | % | n | % | ||
Age (years) | |||||
Mean (SD) | 61 (8,2) | 63,9 (10,8) | 0,225 | ||
Gender | |||||
Male | 15 | 55,6 | 13 | 46,4 | 0,499 |
Female | 12 | 44,4 | 15 | 53,6 | |
Weight (kg, SD) | 76 (19,2) | 78,2 (16,4) | |||
Height (cm, SD) | 171,1 (8,5) | 172,3 (8,7) | |||
Body mass index (BMI) | |||||
Mean (SD) | 25,8 (5,8) | 26,5 (5,7) | 0,899 | ||
Primary site | |||||
Lung cancer | 9 | 33,3 | 10 | 35,7 | |
Breast cancer | 7 | 26,3 | 10 | 35,7 | |
Renal cancer | 2 | 7,4 | 2 | 7,1 | |
Other | 9 | 33,3 | 6 | 21,4 | |
Localization metastases | 0,317 | ||||
Thoracic | 14 | 51,9 | 19 | 67,9 | |
Lumbar | 13 | 48,1 | 8 | 28,6 | |
Number metastases | 0,301 | ||||
1 metastasis | 24 | 88,9 | 22 | 78,6 | |
2 metastases | 3 | 11,1 | 6 | 21,4 | |
Distant metastases at baseline | |||||
Viszeral | 12 | 44,4 | 14 | 51,9 | 0,586 |
Lung | 11 | 40,7 | 4 | 14,8 | 0,033 |
Brain | 7 | 25,9 | 3 | 11,1 | 0,161 |
Tissue | 5 | 18,5 | 4 | 14,8 | 0,715 |
Hormontherapy | 6 | 22,2 | 8 | 28,6 | 0,589 |
Immuntherapy | 8 | 29,6 | 8 | 28,6 | 0,931 |
Chemotherapy | 11 | 40,7 | 13 | 46,4 | 0,671 |
Surgery | 8 | 29,6 | 10 | 35,7 | 0,631 |
Neurological deficit at baseline | 0 | 0 | 1 | 3,6 | 0,322 |
Bisphosphonate at baseline | 11 | 40,7 | 13 | 46,4 | 0,671 |
Orthopedic corset at baseline | 3 | 11,1 | 6 | 21,4 | 0,301 |
Medication at baseline | |||||
Sleeping medication | 1 | 3,7 | 1 | 3,6 | 0,979 |
Psychiatric medication | 3 | 11,1 | 5 | 17,9 | 0,478 |
Opiate | 11 | 40,7 | 10 | 35,7 | 0,701 |
NSAID | 15 | 55,6 | 15 | 53,6 | 0,883 |